A novel immunization method to induce cytotoxic T-lymphocyte responses (CTL) against plasmid-encoded herpes simplex virus type-1 glycoprotein D

Vaccine

Volumn 17, Issue 9-10, 1999, Pages 1091-1099

  Cruz, P E ^a   Khalil, P L ^a   Dryden, T D ^a   Chiou, H C ^b   Fink, P S ^a   Berberich, S J ^c   Bigley, N J ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

^b Orchestra Therapeutics Inc   (United States)

^c WRIGHT STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERPES SIMPLEX VACCINE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CYTOTOXIC T LYMPHOCYTE; FEMALE; GENE TARGETING; HERPES SIMPLEX VIRUS; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, CD4; ASIALOGLYCOPROTEIN RECEPTOR; ASIALOGLYCOPROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMAGGLUTININS, VIRAL; LIVER; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; OROSOMUCOID; PLASMIDS; POLYLYSINE; RECEPTORS, CELL SURFACE; SIMPLEXVIRUS; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; VACCINATION; VIRAL ENVELOPE PROTEINS;

EID: 0033525610     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00326-0     Document Type: Article

References (28)

1. Ulmer J.B., Donnelly J.J., Parker S.E., Rhodes G.H., Felgner P.L., Dwarki V.J., Gromkowski S.H., Deck R.R., DeWitt C.M., Friedman A., Hawe L.A., Leander K.R., Martinez D., Perry H.C., Shiver J.W., Montgomery D.L., Liu M.A. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science. 259:1993;1745-1749.
2. Manickan E., Rouse R.J.D., Yu Z., Wire W.S., Rouse B.T. Genetic immunization against herpes simplex virus. J. Immunol. 155:1995;259-265.
3. Ghiasi H., Cai S., Slanina S., Nesburn A.B., Wechsler S.L. Vaccination of mice with herpes simplex virus type 1 glycoprotein D DNA produces low levels of protection against lethal HSV-1 challenge. Antiviral Res. 28:1995;147-157.
4. Findeis M.A., Wu C.H., Wu G.Y. Ligand-based carrier systems for delivery of DNA to hepatocytes. Meth. Enzymol. 247:1994;341-351.
5. Wilson J.M., Grossman M., Wei C.H., Chowdhury N.R., Wu G.Y., Chwodhury J.R. Hepatocyte-directed gene transfer in vivo leads to transient improvement of hypercholesterolemia in low density lipoprotein receptor-deficient rabbits. J. Biol. Chem. 267:1992;963-967.
6. Braun J.R., Willnow T.E., Ishibashi S., Ashwell G., Herz J. The major subunit of the asialoglycoprotein receptor is expressed on the hepatocellular surface in mice lacking the minor receptor unit. J. Biol. Chem. 271:1996;21160-21166.
7. Fuhrer C., Geffen I., Huggel K., Spiess M. The two subunits of the asialoglycoprotein receptor contain different sorting information. J. Biol.Chem. 269:1994;3277-3282.
8. Hu C.B., Lee E.Y., Baenziger J.U., Mu J.Z., DeSchryver-Kecskemeti K., Alpers D.H. The minor components of the rat asialoglycoprotein receptor are apically located in neonatal enterocytes. Gastroenterol. 101:1991;1477-1487.
9. Mikloska Z., Kesson A.M., Penfold M.E., Cunningham A.L. Herpes simplex virus protein targets for CD4 and CD8 lymphocyte cytotoxicity in cultured epidermal keratinocytes treated with interferon-gamma. J. Infect. Dis. 173:1996;7-17.
10. Ghiasi H., Kaiwar R., Nesburn A.B., Slanina S., Wechsler S.L. Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH and gI): comparative protection against lethal challenge in mice. J. Virol. 68:1994;2118-2126.
11. Isihizaka S.T., Mishkin E.M. Native HSV glycoprotein D subunit vaccine: analysis of in vitro T-cell activation and antigen presentation. Viral. Immunol. 4:1991;187-193.
12. Mishkin E.M., Fahey J.R., Kino Y., Klein R.J., Abramovitz A.S., Mento S.J. Native herpes simplex virus glycoprotein D vaccine: immunogenicity and protection in animal models. Vaccine. 9:1991;147-153.
13. Watary E., Dretzschold B., Szokan G., Heber-Katz E. A synthetic peptide induces long-term protection from lethal infection with herpes simplex virus 2. J. Exp. Med. 165:1987;459-470.
14. Bourne N., Stanberry L.R., Bernstein D.I., Lew D. DNA immunization against experimental genital herpes simplex virus infection. J. Infect. Dis. 173:1996;800-807.
15. Chiou H.C., Tangco M.V., Levine S.M., Robertson D., Kormis K., Wu C.H., Wu G.Y. Enhanced resistance to nuclease degradation of nucleic acids complexed to asialoglycoprotein-polylysine carriers. Nucleic Acids Res. 22:1994;5439-5446.
16. Johnson R.M., Spear P.G. Herpes simplex virus glycoprotein D mediates interference with herpes simplex virus infection. J. Virol. 63:1989;819-827.
17. Johnson R.M., Lancki D.W., Fitch F.W., Spear P.G. Herpes simplex virus glycoprotein D is recognized as antigen by CD4+ and CD8+ T-lymphocytes from infected mice. J. Immunol. 145:1990;702-710.
18. Klaunig J.E., Goldblatt P.J., Hinton D.E., Lipsky M.M., Chacko J., Trump B.F. Mouse liver cell culture. I. Hepatocyte isolation. In Vitro. 17:1981;913-925.
19. Xiaosui J., Gregory S.H., Wing E.J. Immune CD8+ T-lymphocytes lyse listeria monocytogenes-infected hepatocytes by a classical MHC class I-restricted mechanism. J. Immunol. 158:1997;287-293.
20. Coligan J, Kruisbeek A, Margulies D, Shevach E, Stober W. In: Coligan J.E, editor. Current protocols in immunology. Wiley, 1994, p. 2.1.15-2.1.16.
21. Martin S., Moss B., Berman P.W., Laskey L.A., Rouse B.T. Mechanisms of antiviral immunity induced by a vaccine virus recombinant expressing herpes simplex virus type 1 glycoprotein D: cytotoxic T-cells. J. Virol. 61:1987;726-734.
22. Rouse R.J.D., Nair S.K., Lydy S.L., Bowen J.C., Rouse B.T. Induction in vitro of primary cytotoxic T-lymphocyte responses with DNA encoding herpes simplex virus proteins. J. Virol. 68:1994;5685-5689.
23. Jennings S.R., Bonneau R.H., Smith P.M., Wolcott R.M., Chervenak R. CD4-positive T-lymphocytes are required for the generation of the primary but not the secondary CD8-positive cytolytic T-lymphocyte response to herpes simplex virus in C57BL/6 mice. Cell. Immunol. 133:1991;234-252.
24. Dixon B. The third vaccine revolution. Bio/Technology. 13:1995;420.
25. Kolaitis G., Doymaz M., Rouse B.T. Demostration of MHC class II-restricted T-lymphocytes in mice against herpes simplex virus. Immunology. 7:1990;101-106.
26. Koelle D.M., Corey L., Burke R.L., Eisenberg R.J., Chen G.H., Pichyangkura R., Triezenberg S.T. Antigenic specificities of human CD4+ T-cell clones recovered from recurrent genital herpes simplex virus type 2. J. Virol. 68:1994;2803-2810.
27. Chow Y.H., Huang W.L., Chi W.K., Chu Y.D., Tao M.H. Improvement of hepatitis B DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. J. Virol. 71:1997;169-178.
28. Kim J.J., Ayyavoo V., Bagarazzi M.L., Chattergoon M.A., Dang K., Wang B., Boyer J.D., Weiner D.B. J. Immunol. 158:1997;816-826.